OliX Pharmaceuticals Designates Guangzhou RiboBio a Preferred Oligonucleotide Manufacturer
By: OliX Pharmaceuticals, Inc., RiboBio Co. Ltd.
"OliX's experience with RiboBio during the past year has been excellent, and we look forward to expanding our relationship into clinical-grade products," commented Dmitry Samarsky, OliX's Senior Vice President of Technology & Global Business Development.
RiboBio earned preferred status with OliX in acknowledgement of its high product quality, reliability of delivery, outstanding service and overall competitive value. "We are glad to be recognized by OliX as an outstanding manufacturer and supplier of oligonucleotides. We intend to expand our manufacturing offerings and services to OliX on a preferential basis," commented Darko Hrgetic, the Head of the RiboBio's cGMP Manufacturing. The Presidents and CEOs of both companies - Biliang Zhang (RiboBio) and Dong-ki Lee (OliX) - are enthusiastic about strengthening the relationship between the companies.
OliX Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics against a variety of disorders based on RNAi (RNA interference)
RiboBio Co. Ltd. is a biotechnology company with an established comprehensive oligonucleotide manufacturing facility. Equipped with state-of-the-
Lee, Jung Hwan
Strategic Business Management
OliX Pharmaceuticals, Inc.
+86 (20) 3229 0075, ext. 657
Guangzhou RiboBio, Ltd.